US Stock MarketDetailed Quotes

INMB INmune Bio

Watchlist
  • 4.870
  • +0.110+2.31%
Close Nov 22 16:00 ET
  • 4.870
  • 0.0000.00%
Post 20:02 ET
108.35MMarket Cap-2233P/E (TTM)

INmune Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-63.84%-6.99M
-148.46%-7.89M
-555.21%-7.48M
47.19%-11.98M
40.28%-3.4M
-26.64%-4.26M
33.31%-3.17M
87.13%-1.14M
20.41%-22.69M
41.77%-5.7M
Net income from continuing operations
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
Other non cash items
-72.22%15K
-58.62%24K
-49.25%34K
-6.28%224K
-33.82%45K
-6.90%54K
1.75%58K
19.64%67K
89.68%239K
19.30%68K
Change In working capital
43.17%3.37M
-136.56%-514K
-51.66%1.74M
464.39%10.44M
279.45%3.08M
3.70%2.36M
933.82%1.41M
201.04%3.59M
7.19%-2.86M
-1.78%-1.72M
-Change in receivables
1,018.43%1.99M
-540.85%-723K
-103.97%-248K
303.55%6.02M
95.45%-179K
-141.02%-217K
-72.11%164K
4,440.97%6.25M
20.19%-2.96M
-997.77%-3.93M
-Change in prepaid assets
-88.85%134K
-87.22%119K
32.32%520K
236.18%2.41M
-117.70%-117K
367.71%1.2M
127.63%931K
116.44%393K
14.62%-1.77M
167.59%661K
-Change in payables and accrued expense
-14.88%1.22M
-82.07%71K
146.50%1.41M
23.84%2.17M
84.69%3.38M
-22.90%1.44M
151.03%396K
-161.03%-3.04M
-28.74%1.75M
654.24%1.83M
-Change in other current assets
-200.00%-1K
180.65%25K
--25K
---32K
---2K
--1K
---31K
--0
--0
--0
-Change in other current liabilities
-25.00%-5K
69.57%-7K
-146.15%-6K
87.88%-4K
108.62%10K
-116.00%-4K
-200.00%-23K
-62.86%13K
-171.74%-33K
-357.78%-116K
-Change in other working capital
143.75%28K
103.23%1K
224.00%31K
-189.44%-127K
95.68%-7K
-121.19%-64K
71.30%-31K
-122.73%-25K
-50.00%142K
-141.79%-162K
Cash from discontinued investing activities
Operating cash flow
-63.84%-6.99M
-148.46%-7.89M
-555.21%-7.48M
47.19%-11.98M
40.28%-3.4M
-26.64%-4.26M
33.31%-3.17M
87.13%-1.14M
20.41%-22.69M
41.77%-5.7M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
667.65%9.79M
13M
-2.5M
-679.56%-4.23M
-2.5M
-1.73M
0
0
-99.24%729K
0
Net issuance payments of debt
0.00%-2.5M
---2.5M
---2.5M
---5M
---2.5M
---2.5M
--0
--0
--0
--0
Net common stock issuance
1,486.06%12.29M
----
----
10.87%775K
--0
--775K
----
----
-99.13%699K
--0
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-97.40%30K
--0
Cash from discontinued financing activities
Financing cash flow
667.65%9.79M
--13M
---2.5M
-679.56%-4.23M
---2.5M
---1.73M
--0
--0
-99.24%729K
--0
Net cash flow
Beginning cash position
-35.04%31.07M
-49.02%26M
-31.26%35.85M
-30.29%52.15M
-27.16%41.81M
-21.87%47.83M
-23.57%51M
-30.29%52.15M
240.56%74.81M
-32.04%57.41M
Current changes in cash
146.85%2.81M
261.03%5.11M
-774.32%-9.98M
26.20%-16.21M
-3.62%-5.9M
-77.87%-5.99M
33.31%-3.17M
85.98%-1.14M
-141.54%-21.96M
41.77%-5.7M
Effect of exchange rate changes
-1,304.35%-323K
-1,000.00%-44K
1,544.44%130K
85.71%-100K
-114.45%-64K
94.78%-23K
99.47%-4K
-116.36%-9K
-6,900.00%-700K
272.27%443K
End cash Position
-19.76%33.55M
-35.04%31.07M
-49.02%26M
-31.26%35.85M
-31.26%35.85M
-27.16%41.81M
-21.87%47.83M
-23.57%51M
-30.29%52.15M
-30.29%52.15M
Free cash flow
-63.84%-6.99M
-148.46%-7.89M
-555.21%-7.48M
47.19%-11.98M
40.28%-3.4M
-26.64%-4.26M
33.31%-3.17M
87.13%-1.14M
47.85%-22.69M
41.77%-5.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -63.84%-6.99M-148.46%-7.89M-555.21%-7.48M47.19%-11.98M40.28%-3.4M-26.64%-4.26M33.31%-3.17M87.13%-1.14M20.41%-22.69M41.77%-5.7M
Net income from continuing operations -41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M
Other non cash items -72.22%15K-58.62%24K-49.25%34K-6.28%224K-33.82%45K-6.90%54K1.75%58K19.64%67K89.68%239K19.30%68K
Change In working capital 43.17%3.37M-136.56%-514K-51.66%1.74M464.39%10.44M279.45%3.08M3.70%2.36M933.82%1.41M201.04%3.59M7.19%-2.86M-1.78%-1.72M
-Change in receivables 1,018.43%1.99M-540.85%-723K-103.97%-248K303.55%6.02M95.45%-179K-141.02%-217K-72.11%164K4,440.97%6.25M20.19%-2.96M-997.77%-3.93M
-Change in prepaid assets -88.85%134K-87.22%119K32.32%520K236.18%2.41M-117.70%-117K367.71%1.2M127.63%931K116.44%393K14.62%-1.77M167.59%661K
-Change in payables and accrued expense -14.88%1.22M-82.07%71K146.50%1.41M23.84%2.17M84.69%3.38M-22.90%1.44M151.03%396K-161.03%-3.04M-28.74%1.75M654.24%1.83M
-Change in other current assets -200.00%-1K180.65%25K--25K---32K---2K--1K---31K--0--0--0
-Change in other current liabilities -25.00%-5K69.57%-7K-146.15%-6K87.88%-4K108.62%10K-116.00%-4K-200.00%-23K-62.86%13K-171.74%-33K-357.78%-116K
-Change in other working capital 143.75%28K103.23%1K224.00%31K-189.44%-127K95.68%-7K-121.19%-64K71.30%-31K-122.73%-25K-50.00%142K-141.79%-162K
Cash from discontinued investing activities
Operating cash flow -63.84%-6.99M-148.46%-7.89M-555.21%-7.48M47.19%-11.98M40.28%-3.4M-26.64%-4.26M33.31%-3.17M87.13%-1.14M20.41%-22.69M41.77%-5.7M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 667.65%9.79M13M-2.5M-679.56%-4.23M-2.5M-1.73M00-99.24%729K0
Net issuance payments of debt 0.00%-2.5M---2.5M---2.5M---5M---2.5M---2.5M--0--0--0--0
Net common stock issuance 1,486.06%12.29M--------10.87%775K--0--775K---------99.13%699K--0
Proceeds from stock option exercised by employees --------------0-----------------97.40%30K--0
Cash from discontinued financing activities
Financing cash flow 667.65%9.79M--13M---2.5M-679.56%-4.23M---2.5M---1.73M--0--0-99.24%729K--0
Net cash flow
Beginning cash position -35.04%31.07M-49.02%26M-31.26%35.85M-30.29%52.15M-27.16%41.81M-21.87%47.83M-23.57%51M-30.29%52.15M240.56%74.81M-32.04%57.41M
Current changes in cash 146.85%2.81M261.03%5.11M-774.32%-9.98M26.20%-16.21M-3.62%-5.9M-77.87%-5.99M33.31%-3.17M85.98%-1.14M-141.54%-21.96M41.77%-5.7M
Effect of exchange rate changes -1,304.35%-323K-1,000.00%-44K1,544.44%130K85.71%-100K-114.45%-64K94.78%-23K99.47%-4K-116.36%-9K-6,900.00%-700K272.27%443K
End cash Position -19.76%33.55M-35.04%31.07M-49.02%26M-31.26%35.85M-31.26%35.85M-27.16%41.81M-21.87%47.83M-23.57%51M-30.29%52.15M-30.29%52.15M
Free cash flow -63.84%-6.99M-148.46%-7.89M-555.21%-7.48M47.19%-11.98M40.28%-3.4M-26.64%-4.26M33.31%-3.17M87.13%-1.14M47.85%-22.69M41.77%-5.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data